157 related articles for article (PubMed ID: 19293824)
1. Correction for the effect of rising plasma glucose levels on quantification of MR(glc) with FDG-PET.
Dunn JT; Anthony K; Amiel SA; Marsden PK
J Cereb Blood Flow Metab; 2009 May; 29(5):1059-67. PubMed ID: 19293824
[TBL] [Abstract][Full Text] [Related]
2. Operational lumped constant for FDG in normal adult male rats.
Tokugawa J; Ravasi L; Nakayama T; Schmidt KC; Sokoloff L
J Nucl Med; 2007 Jan; 48(1):94-9. PubMed ID: 17204704
[TBL] [Abstract][Full Text] [Related]
3. Whiskers area as extracerebral reference tissue for quantification of rat brain metabolism using (18)F-FDG PET: application to focal cerebral ischemia.
Backes H; Walberer M; Endepols H; Neumaier B; Graf R; Wienhard K; Mies G
J Nucl Med; 2011 Aug; 52(8):1252-60. PubMed ID: 21764786
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 1-(11)C-glucose and (18)F-FDG for quantifying myocardial glucose use with PET.
Herrero P; Sharp TL; Dence C; Haraden BM; Gropler RJ
J Nucl Med; 2002 Nov; 43(11):1530-41. PubMed ID: 12411556
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of heterogeneity in tumor metabolism using FDG-PET.
Vriens D; Disselhorst JA; Oyen WJ; de Geus-Oei LF; Visser EP
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e725-31. PubMed ID: 22330998
[TBL] [Abstract][Full Text] [Related]
6. Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography.
Toyama H; Ichise M; Liow JS; Modell KJ; Vines DC; Esaki T; Cook M; Seidel J; Sokoloff L; Green MV; Innis RB
J Nucl Med; 2004 Aug; 45(8):1398-405. PubMed ID: 15299067
[TBL] [Abstract][Full Text] [Related]
7. The (18)F-fluorodeoxyglucose lumped constant determined in human brain from extraction fractions of (18)F-fluorodeoxyglucose and glucose.
Hasselbalch SG; Holm S; Pedersen HS; Svarer C; Knudsen GM; Madsen PL; Paulson OB
J Cereb Blood Flow Metab; 2001 Aug; 21(8):995-1002. PubMed ID: 11487735
[TBL] [Abstract][Full Text] [Related]
8. A curve-fitting approach to estimate the arterial plasma input function for the assessment of glucose metabolic rate and response to treatment.
Vriens D; de Geus-Oei LF; Oyen WJ; Visser EP
J Nucl Med; 2009 Dec; 50(12):1933-9. PubMed ID: 19910436
[TBL] [Abstract][Full Text] [Related]
9. Error sensitivity of fluorodeoxyglucose method for measurement of cerebral metabolic rate of glucose.
Huang SC; Phelps ME; Hoffman EJ; Kuhl DE
J Cereb Blood Flow Metab; 1981; 1(4):391-401. PubMed ID: 6976976
[TBL] [Abstract][Full Text] [Related]
10. Quantification of cerebral glucose metabolic rate in mice using 18F-FDG and small-animal PET.
Yu AS; Lin HD; Huang SC; Phelps ME; Wu HM
J Nucl Med; 2009 Jun; 50(6):966-73. PubMed ID: 19443595
[TBL] [Abstract][Full Text] [Related]
11. Is the physical decay correction of the (18)F-FDG input function in dynamic PET imaging justified?
Laffon E; Barret O; Marthan R; Ducassou D
J Nucl Med Technol; 2009 Jun; 37(2):111-3. PubMed ID: 19447853
[TBL] [Abstract][Full Text] [Related]
12. Simplifications in analyzing positron emission tomography data: effects on outcome measures.
Logan J; Alexoff D; Kriplani A
Nucl Med Biol; 2007 Oct; 34(7):743-56. PubMed ID: 17921027
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: a validation study.
Iozzo P; Gastaldelli A; Järvisalo MJ; Kiss J; Borra R; Buzzigoli E; Viljanen A; Naum G; Viljanen T; Oikonen V; Knuuti J; Savunen T; Salvadori PA; Ferrannini E; Nuutila P
J Nucl Med; 2006 Jun; 47(6):1016-22. PubMed ID: 16741312
[TBL] [Abstract][Full Text] [Related]
14. Spillover and partial-volume correction for image-derived input functions for small-animal 18F-FDG PET studies.
Fang YH; Muzic RF
J Nucl Med; 2008 Apr; 49(4):606-14. PubMed ID: 18344438
[TBL] [Abstract][Full Text] [Related]
15. Calculation of the FDG lumped constant by simultaneous measurements of global glucose and FDG metabolism in humans.
Hasselbalch SG; Madsen PL; Knudsen GM; Holm S; Paulson OB
J Cereb Blood Flow Metab; 1998 Feb; 18(2):154-60. PubMed ID: 9469157
[TBL] [Abstract][Full Text] [Related]
16. Sympathetic activity at rest and motor brain areas: FDG-PET study.
Schlindwein P; Buchholz HG; Schreckenberger M; Bartenstein P; Dieterich M; Birklein F
Auton Neurosci; 2008 Dec; 143(1-2):27-32. PubMed ID: 18723403
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
[TBL] [Abstract][Full Text] [Related]
18. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
Albin RL; Koeppe RA; Burke JF; Giordani B; Kilbourn MR; Gilman S; Frey KA
Arch Neurol; 2010 Apr; 67(4):440-6. PubMed ID: 20385910
[TBL] [Abstract][Full Text] [Related]
19. In vivo quantification of 18f-fdg uptake in human placenta during early pregnancy.
Zanotti-Fregonara P; Jan S; Champion C; Trébossen R; Maroy R; Devaux JY; Hindié E
Health Phys; 2009 Jul; 97(1):82-5. PubMed ID: 19509511
[TBL] [Abstract][Full Text] [Related]
20. Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling.
Shimoji K; Ravasi L; Schmidt K; Soto-Montenegro ML; Esaki T; Seidel J; Jagoda E; Sokoloff L; Green MV; Eckelman WC
J Nucl Med; 2004 Apr; 45(4):665-72. PubMed ID: 15073264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
